HopeStage
Back to all studies
RecruitingNCT06707012

Metformin added to antidepressants for adults with obesity and depression

About this titleRead the official source — NCT06707012
Medication studyAges 18–45Pakistan
The study in practice

Understand this study

Who could participate?

This study is for people with depression. Listed age limits: 18 years to 45 years. Other eligibility criteria apply.

Listed locations
Karachi and 1 more locationSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateEstimated: October 1, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
140
Sponsor
Fazaia Ruth Pfau Medical College
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Pakistan
Age range
From 18 Years to 45 Years
Official registry ID
NCT06707012
Official title
Show the full official title

Efficacy of Metformin as an Adjunct to Standard Antidepressant Therapy in Treating Depression Among Obese Patients

Recruitment & locations

Currently recruiting

Karachi

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Fazaia Ruth Pfau Medical College, a university.

Does this study involve medication?

Yes. The study involves medication, including Metformin Hydrochloride.

Who can participate?

This study is for people with depression. Listed age limits: 18 years to 45 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies